Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.42 and traded as low as $0.3566. Elite Pharmaceuticals shares last traded at $0.3599, with a volume of 451,833 shares.
Elite Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 0.05, a current ratio of 7.34 and a quick ratio of 5.44. The stock’s 50 day simple moving average is $0.36 and its two-hundred day simple moving average is $0.42. The stock has a market cap of $387.66 million, a price-to-earnings ratio of 12.00 and a beta of 0.38.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
